Related Experiment Video
Updated: May 30, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Mitochondrial DNA alterations in precision oncology: Emerging roles in diagnostics and therapeutics
Alexis Germán Murillo Carrasco1, Roger Chammas1, Tatiane Katsue Furuya1
1Centro de Investigação Translacional em Oncologia (LIM24), Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil; Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo, Brazil.
Abstract:
Mitochondria are dynamic organelles essential for vital cellular functions, including ATP production, apoptosis regulation, and calcium homeostasis. Increasing research has highlighted the significance of mitochondrial DNA (mtDNA) content and alterations in the development and progression of various diseases, including cancer. The high mutation rate and vulnerability of mtDNA to damage make these alterations valuable biomarkers for cancer diagnosis, monitoring disease progression, detecting metastasis, and predicting treatment resistance across different tumor types. This review explores the emerging roles of mtDNA alterations in precision oncology, emphasizing their potential in theranostics. The authors explore the mechanisms by which mtDNA mutations contribute to tumorigenesis and therapy resistance, the impact of heteroplasmy in cancer biology, and the integration of mtDNA-based diagnostics with current therapeutic strategies. Additionally, the authors highlight the experimental tools and models currently used to investigate mtDNA alterations in cancer, including advanced sequencing technologies and animal models.
Insights
Mitochondrial DNA (mtDNA) alterations are crucial biomarkers in cancer, aiding diagnosis, progression monitoring, and predicting treatment resistance. Their role in precision oncology and theranostics is rapidly expanding.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Mitochondria are vital organelles involved in cellular functions like ATP production and apoptosis.
- Mitochondrial DNA (mtDNA) alterations are increasingly recognized for their role in disease development, particularly cancer.
- The unique properties of mtDNA make it a promising source for cancer biomarkers.
Purpose of the Study:
- To review the emerging roles of mtDNA alterations in precision oncology.
- To emphasize the potential of mtDNA alterations in theranostics (diagnosis and therapy).
- To explore the integration of mtDNA-based diagnostics with current cancer treatment strategies.
Main Methods:
- Review of current literature on mtDNA alterations in cancer.
- Exploration of mechanisms linking mtDNA mutations to tumorigenesis and therapy resistance.
- Discussion of experimental tools and models for investigating mtDNA alterations, including advanced sequencing and animal models.
Main Results:
- mtDNA alterations serve as valuable biomarkers for cancer diagnosis, monitoring, metastasis detection, and predicting treatment resistance.
- mtDNA mutations contribute to cancer development and influence therapy resistance.
- Heteroplasmy (coexistence of different mtDNA types) plays a significant role in cancer biology.
Conclusions:
- mtDNA alterations hold significant promise for advancing precision oncology and theranostics.
- Integrating mtDNA diagnostics with therapeutic strategies can personalize cancer care.
- Further research using advanced tools is essential to fully leverage mtDNA alterations in cancer management.
Related Concept Videos
Animal Mitochondrial Genetics
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

